-
21.发明授权公开(公告)号：US10291417B2
公开(公告)日：2019-05-14
申请号：US11959680
申请日：2007-12-19
摘要： A method and system for providing distributed network access point installation and management. A network provider installs and/or operates a plurality of access points at locations of a retail entity. Each access point may provide services such as Internet access, and/or content such as audio, video, text, and/or graphics, among other types of services. A carrier, such as a telephone or cable company, may compensate the network service provider for installation and operation of the access points. The carrier may in turn charge its subscribers for network access at the retail entity locations. A plurality of different carriers may provide compensation and allow respective subscriber access. The network access points may be configured to allow each carrier to present a point of presence to its subscribers at the retail entity locations. The installed network may also provide service for retail entity back office functions.
-
公开(公告)号：US07112601B2
公开(公告)日：2006-09-26
申请号：US10922096
申请日：2004-08-19
IPC分类号： A61K31/415 , C07D231/12 , C07D231/14 , C07D231/16
CPC分类号： C07D231/12 , C07D231/14
摘要： Compounds of Formula I are disclosed which inhibit hepatitis C NS5B RNA-dependent RNA polymerase and are useful for treating hepatitis C. Compositions and methods of using these compounds are also disclosed
摘要翻译： 公开了抑制丙型肝炎NS5B RNA依赖性RNA聚合酶并可用于治疗丙型肝炎的式I化合物。也公开了使用这些化合物的组合物和方法
-
公开(公告)号：US5380854A
公开(公告)日：1995-01-10
申请号：US92402
申请日：1993-07-14
IPC分类号： C07D263/32 , C07D263/34 , C07D413/04 , C07D413/14 , C07D417/04
CPC分类号： C07D263/34 , C07D263/32 , C07D413/04 , C07D413/14 , C07D417/04
摘要： A novel series of oxazole derivatives having enhanced water solubility bioavailability and metabolic stability is disclosed in the Formula I ##STR1## or pharmaceutically acceptable salt thereof.
摘要翻译： 公式I
r Th中公开了一系列具有增强的水溶性生物利用度和代谢稳定性的恶唑衍生物。 R2是H，CN，CO2R3或OR3; 且R 3为H或C 1 -C 4低级烷基; 或其药学上可接受的盐。 -
公开(公告)号：US5254576A
公开(公告)日：1993-10-19
申请号：US862680
申请日：1992-04-03
IPC分类号： C07D263/32 , C07D263/34 , C07D413/04 , C07D413/14 , C07D417/04 , A61K31/54 , A61K31/535
CPC分类号： C07D263/34 , C07D263/32 , C07D413/04 , C07D413/14 , C07D417/04
摘要： A novel series of oxazole derivatives having enhanced water solubility bioavailability and metabolic stability is disclosed in the Formula I ##STR1## X is ##STR2## R is CH.sub.2 R.sup.2, H; R.sup.1 is Ph or Th;R.sup.2 is ##STR3## H, CN, CO.sub.2 R.sup.3, or OR.sup.3 ; and R.sup.3 is H, or C.sub.1 -C.sub.4 lower alkyl;or pharmaceutically acceptable salt thereof.
摘要翻译： 在式I中公开了一系列具有增强的水溶性生物利用度和代谢稳定性的恶唑衍生物，其中R是CH 2 R 2，H; R1为Ph或Th; R2是H，CN，CO2R3或OR3; 且R 3为H或C 1 -C 4低级烷基; 或其药学上可接受的盐。
-
公开(公告)号：US06479482B2
公开(公告)日：2002-11-12
申请号：US09852983
申请日：2001-05-10
IPC分类号： C07D41714
CPC分类号： C07D401/12 , C07D211/90
摘要： A series of non-peptidergic antagonists of NPY have been synthesized and are comprises of amino and piperazine derivatives of 4-phenyl-1,4-dihydropyridines of Formula 1. where X is CH or N As antagonists of NPY-induced behavior, these compounds are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
摘要翻译： 已经合成了一系列NPY的非肽能拮抗剂，其由式1的4-苯基-1,4-二氢吡啶的氨基和哌嗪衍生物组成。其中X是NPY诱导行为的CH或NAs拮抗剂，这些化合物是 预期在促进减肥和治疗进食障碍中起到有效的厌氧剂的作用。
-
-
-
-
搜索结果
25 条记录 (耗时 0.056 秒)
